About Korean Institute of Tuberculosis
Clinical Trials at Korean Institute of Tuberculosis
During the past decade, Korean Institute of Tuberculosis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Korean Institute of Tuberculosis"
#1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Korean Institute of Tuberculosis
According to Clinical.Site data, the most researched conditions in "Korean Institute of Tuberculosis" are
"Latent Tuberculosis Infection" (1 trials) and "TB" (1 trials). Many other conditions were trialed in "Korean Institute of Tuberculosis" in a lesser frequency.
Clinical Trials Intervention Types at Korean Institute of Tuberculosis
Most popular intervention types in "Korean Institute of Tuberculosis" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Isoniazid" (1 trials), "Rifampin" (1 trials) and "levofloxacin, moxifloxacin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Korean Institute of Tuberculosis
The vast majority of trials in "Korean Institute of Tuberculosis" are
2 trials for "All" genders.
Clinical Trials Status at Korean Institute of Tuberculosis
Currently, there are NaN active trials in "Korean Institute of Tuberculosis".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Korean Institute of Tuberculosis,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Korean Institute of Tuberculosis, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".